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Patients from five clinics in North and South Carolina who had lesions suggestive of primary or secondary
syphilis were evaluated using molecular techniques that allow the differentiation of Treponema pallidum strains
on the basis of two variable genes, tpr and arp. Lesion samples were screened for the presence of T. pallidum
DNA using PCR for polA, which represents a segment of the polymerase I gene that is unique to the spirochete.
Twenty-seven of 154 lesion samples were found to contain T. pallidum, 23 of which had typeable DNA. Seven
molecular subtypes were found (10f, 12f, 13f, 14f, 14g, 15f, and 16f); one to four subtypes were identified at each
clinic. Subtype 14f was found in 52% of the typeable specimens and was distributed in four of the five clinics.
Subtype 16f was found in 22% of specimens and was concentrated at one clinic. Further data are needed to
define the role of this technique in examining the epidemiology of syphilis.
Syphilis is a sexually transmitted infection associated with an
increased risk of acquisition and transmission of human im-
munodeficiency virus (HIV); infection in mothers can result in
substantial congenital morbidity. Syphilis is endemic across the
southeastern United States. In this region, several areas main-
tain rates that greatly exceed the Centers for Disease Control
and Prevention’s (CDC’s) year 2000 objective of 4 cases of
syphilis per 100,000 persons. In 2000, North Carolina had a
rate of 18.6 cases per 100,000 and South Carolina had a rate of
21.4 per 100,000 for all stages of syphilis compared to a na-
tional rate of 11.2 per 100,000 (2).
Beginning in 1999, the CDC embarked on an effort to pro-
mote syphilis elimination as a national goal (1, 10). One facet
of the plan was to monitor syphilis transmission in areas of
endemicity and prevent outbreaks that result from dissemina-
tion of syphilis into areas that had not experienced recent
transmission.
Prior to the development of a subtyping system, studying the
epidemiologic relationships of syphilis in areas of endemicity
and in focal outbreaks was not possible. Identification and
culture of Treponema pallidum subsp. pallidum, the causative
agent of syphilis, is complicated by the lack of a sustainable
culturing system (3). Recent development at the CDC of a
subtyping method using molecular techniques (9) may allow
the creation of endemicity maps of “local” syphilis strains. This
subtyping method for T. pallidum would allow the monitoring
of changes in the prevalence and geographical distribution of
strains over time and would determine which strains are intro-
duced during outbreaks.
In North Carolina in the late 1990s, there was an increase
in syphilis which appeared to spread from west to east across
the central part of the state (http://www.cdc.gov/std/Syphilis
/syphilis-stats-all-years.htm). This presented a unique opportu-
nity to study the epidemiology of syphilis and to determine the
interstrain variability of T. pallidum within selected regions of
the Carolinas.
MATERIALS AND METHODS
Patient enrollment. Patients were enrolled in the study from five sexually
transmitted disease clinics located in public health departments in North Caro-
lina and South Carolina between November 1999 and January 2003. The dura-
tions of study participation by clinic differed due to requirements for approvals
and other operational issues. Persons who had moist lesions (chancres, condy-
loma lata, or mucous patches) consistent with primary or secondary syphilis were
eligible for enrollment. The protocol called for all routine clinical specimens to
be collected prior to any study samples. Each clinic performed an initial diag-
nostic evaluation, which included dark-field microscopy or direct fluorescent
antibody for T. pallidum (DFA-TP) and the rapid plasma reagin (RPR) tests.
Swab specimens from lesions, slides of lesion exudates, and serum samples were
then collected for research purposes and sent to the CDC, where the RPR, T.
pallidum particle agglutination, and DFA-TP tests and PCR for T. pallidum (6)
were performed. Slides used for dark-field microscopy were air dried before
being sent to the CDC for DFA-TP. All enrollees received appropriate treatment
according to the usual clinical practices during their clinic visits. Institutional
Review Board approval was obtained from the University of North Carolina at
Chapel Hill, the North Carolina Department of Health and Human Services, the
South Carolina Department of Health and Environmental Control, and the
CDC.
Laboratory methods. Lesion specimens were collected on swabs. Each swab
was swirled vigorously in a tube of transport medium (AMPLICOR STD swab
specimen collection and transport kit; Roche Diagnostic Systems, Branchburg,
N.J.), pressed against the side of the tube to express excess liquid, and then
discarded. The tube was capped and stored in a freezer at 20°C until it was
shipped to the CDC on dry ice. The tubes were stored at 70°C until they were
tested by PCR to detect the polA gene of T. pallidum (6). DNA was isolated from
the ulcer exudate samples using a blood and tissue kit (QIAGEN, Valencia,
Calif.) according to the manufacturer’s instructions. The primers used, based on
a 395-bp region of the polA gene that is unique to T. pallidum, were a 25-mer
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forward primer (5-CGTCTGGTCGATGTGCAAATGAGTG-3) and a 26-mer
reverse primer (5-TGCACATGTACACTGAGTTGACTCGG-3).
Samples that tested positive for the polA gene were subtyped using PCR,
followed by gel electrophoresis to determine the number of acidic repeat protein
gene (arp) repeats and restriction fragment length polymorphism to determine
the banding pattern of the T. pallidum repeat protein gene (tpr) (9). The primers
for amplification of the arp gene were a 20-mer forward primer (5-CAAGTC
AGGACGGACTGTCC-3) and an 18-mer reverse primer (5-GGTATCACCT
GGGGATGC-3) that were selected from unique sequences flanking the repeat
region. The amplicon was electrophoresed on a 0.8% to 1.0% agarose gel to
determine the number of repeats present in the T. pallidum strain.
A nested PCR was used to amplify the tpr gene. The first primer pair, derived
from conserved regions in the tpr homologs, consisted of a 20-mer forward
primer (5-ACTGGCTCTGCCACACTTGA-3) and a 20-mer reverse primer
(5-CTACCAGGAGAGGGTGAAGC-3). The second primer pair, based on an
internal region of the PCR product obtained from the first amplification of the
tpr gene, was a 19-mer forward primer (5-CAGGTTTTGCCGTTAAGC-3) and
a 20-mer reverse primer (5-AATCAAGGGAGAATACCGTC-3). The ampli-
con was then digested with the restriction endonuclease MseI. The digested
product was electrophoresed on a 1.5% to 2.0% agarose gel to determine the
digestion pattern (a through i), with the sizes and patterns analyzed using an
ABI310 genetic analyzer (Applied Biosystems, Foster City, Calif.) (6, 8).
All serum samples were tested at the CDC using standard procedures for the
RPR and the T. pallidum particle agglutination tests (5). Air-dried lesion exudate
smears were examined using DFA-TP (5). The slides were fixed for 10 seconds
in 100% methanol and then stained for 30 min using fluorescein isothiocyanate-
labeled monoclonal antibody against the 37-kDa protein of T. pallidum.
RESULTS
A total of 154 persons from the five clinics were enrolled
(Table 1). Sixty-eight percent of the participants were male;
67% were between 20 and 39 years of age. The Wake County
clinic enrolled 74% of all the participants (Table 1) throughout
the 38-month study period. Enrollment periods at the other
sites varied from 2 months to 27 months. No enrolled cases
were known sexual partners of other study participants or
otherwise epidemiologically linked.
A total of 27 lesion specimens were positive by polA PCR,
indicating the presence of T. pallidum DNA. All were from
participants who had a clinical diagnosis of syphilis. Fifteen of
the 27 specimens were from primary syphilis cases, 9 from
secondary syphilis cases, and 3 from cases whose stage of
syphilis was not provided (Table 2). polA was detected in a
higher proportion of specimens from secondary syphilis cases
than from primary syphilis cases (75% versus 36%).
Of the 27 polA-positive samples, 23 contained sufficient
DNA for typing, including all 8 samples that were negative by
dark-field microscopy and DFA-TP (Table 3). A total of seven
subtypes were identified, with one to four subtypes at each
clinic (Table 4). Subtype 14f was the most common, accounting
for 52% of all typeable samples. Subtype 14f was found in all
four North Carolina clinics and among primary and secondary
syphilis cases (six and five cases, respectively). Four of the five
16f subtypes were found in one clinic, with one from a second-
ary syphilis case and four from primary syphilis cases. The 16f
subtypes clustered around a 1-month time frame, with a 14f
subtype appearing 4 months later in the same clinic (data not
shown).
Results were available for dark-field microscopy, DFA-TP
(CDC results), and polA testing from 135 participants (Table
3). CDC results for DFA-TP were used because there were
only a small number of results available. There was agreement
among all three tests for 112 participants (105 all negative; 7 all
TABLE 1. Demographic characteristics of 154 participants
Characteristic No. (%)a
Gender
Female ........................................................................................ 49 (32)
Male ............................................................................................105 (68)









Native American ....................................................................... 12 (8)
White .......................................................................................... 14 (9)
Clinic site
Durham County, NC ................................................................ 17 (11)
Guilford County, NC ................................................................ 5 (3)
Richland County, SC ................................................................ 2 (1)
Robeson County, NC................................................................ 16 (10)
Wake County, NC.....................................................................114 (74)
a Percentages may not equal 100 due to rounding.
TABLE 2. polA results by clinical diagnosis of genital lesion




Stage not given...................................................................... 3/7 (43)
Herpes........................................................................................ 0/48
Other .......................................................................................... 0/32
Not specified ............................................................................. 0/13
a Number positive by polA/number with clinical diagnosis.













Negative 105 1 7 1
Positive 8 5 1 7
a N, negative; P, positive.
TABLE 4. Distribution of Treponema pallidum subtypes by county
Clinic site Subtype(s) (no.)a
Durham County ....................................14f (1)
Guilford County....................................12f (1), 14f (1), 15f (1)
Richland County ...................................16f (1)
Robeson County ...................................14f (1), 16f (4)
Wake County.........................................10f (2), 13f (1), 14f (9), 14g (1)
a Number of individuals with subtype.
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positive). As mentioned above, eight patients had lesion spec-
imens negative by dark-field microscopy and DFA-TP tests but
positive on polA PCR. All but one of these patients had reac-
tive RPR tests (titers from 1:8 to 1:256). Seven patients had
lesion specimens that were positive only by dark-field micros-
copy.
DISCUSSION
In this study of T. pallidum subtypes in North and South
Carolina, a total of seven subtypes were identified from pa-
tients with lesions consistent with primary or secondary syph-
ilis. These subtypes included two tpr subtypes (f and g) and five
arp subtypes (sizes 10, 12, 13, 14, and 16). Previous studies
indicated that f and g subtypes differed by four bands while the
arp subtypes differ by size (8). The most common subtype
identified in our study was 14f. More than half of the typeable
specimens were 14f, which was detected in participants from
four of the five clinics. The only other large-scale study of T.
pallidum subtypes conducted in the United States was done in
Maricopa County, Arizona (11). The age and gender distribu-
tions of the participants in both studies were similar; however,
the Maricopa study population was predominately Hispanic
while our study population was predominately African Amer-
ican. In both studies, 14f was the predominant subtype. How-
ever, in the Carolinas, which represented a wider geographic
area, fewer subtypes were identified (7 in the Carolinas; 10 in
Maricopa). This may have been due to the larger number of
isolates in Arizona. The greatest diversity in subtypes noted in
our study occurred in Wake County, North Carolina, where the
majority of the participants were enrolled.
Of note, subtype 16f appeared only during a short time
frame and primarily at one clinic in Robeson County, which is
located in the southeastern part of North Carolina along In-
terstate 95 near the South Carolina border. The only other 16f
subtype was detected almost a year earlier at a clinic in Rich-
land County, South Carolina, which is also on the Interstate 95
corridor. Although the numbers are small, this suggests a clus-
ter of related syphilis cases that were unrelated to the other
cases that presented in central North Carolina.
In other studies that included international sites (8, 9), sub-
types 12f, 14f, and 16f were not identified outside the United
States. Subtype 14g has been identified in Durban, South Af-
rica (8), but not previously in the United States (7, 9). Subtypes
10f, 13f, and 15f have not been previously identified in the
United States or international sites (7, 8, 9), while other sub-
types not identified in our study have been reported from both
African and U.S. sites. Of these, subtype 14d was most preva-
lent in Africa (9), and it has also been reported in the United
States (Birmingham, Ala.; Chicago, Ill.; and Phoenix, Ariz.)
(8).
The presence of HIV infection may influence the clinical
presentation of syphilis. Because the known HIV prevalence in
this study was low, and patients were not systematically tested,
we cannot evaluate any relationship between HIV infection
and the syphilis subtype or polA detection rate.
Since PCR can detect smaller numbers of organisms (6) than
dark-field microscopy or DFA-TP, it is not surprising that
some patients in our study had positive polA results with neg-
ative dark-field microscopy and DFA-TP test results. All of
these patients’ specimens had typeable T. pallidum DNA, and
all but one had reactive RPR tests, suggesting that these results
were true positives. Unfortunately, PCR for detection of T.
pallidum is not commercially available, and the time required
to conduct the test is not practical for use in sexually transmit-
ted disease clinics, where it would be most useful.
There were two ulcer samples that were positive by DFA-TP
but negative by PCR. A possible explanation for this finding is
that the numbers of treponemes in the samples were low;
furthermore, since the protocol called for collection of clinical
samples prior to any study samples, there may have been too
few spirochetes to be detected by PCR from the second swab.
Another possibility is that the DFA-TP was falsely positive.
The monoclonal antibody that was used in the DFA-TP is
directed against the 37-kDa protein, which is a flagellar pro-
tein. In the original studies that were performed, this mono-
clonal antibody reacted only with T. pallidum subspecies (4).
However, cross-reactivity with possible contaminating gastro-
intestinal spirochetes cannot be entirely ruled out.
One limitation of this study was that only 36% of the spec-
imens from patients with a clinical diagnosis of primary syphilis
were polA positive, which was a lower percentage than in a
previous study (11). Factors that may be responsible for this
include inadequate sample collection, collection of study sam-
ples after clinical samples, enrollment of patients with partially
healed ulcers, possible self-medication with topical medica-
tions by the patients, and overdiagnosis of primary syphilis.
The relatively low proportion of specimens with detectable
polA may have skewed the measured distribution of subtypes in
the population. Another limitation is that we may not have
enrolled all the patients with primary or secondary syphilis who
presented to the clinics during the study period, which affected
the number of specimen subtypes that were identified in this
study.
The data presented here suggest that T. pallidum subtyping
based on variability in the arp and tpr genes may be a useful
epidemiologic tool. In this study, we did not have a sufficient
number of syphilis cases to determine local trends or move-
ment of strains, and no patients representing epidemiologically
linked cases were enrolled. Studies carried out over a longer
time frame need to be performed, with more-vigorous at-
tempts to obtain adequate lesion samples from patients with
primary or secondary syphilis. Results from prior investigations
(7, 11) indicate that whole blood could also be used to deter-
mine T. pallidum subtypes, which may be a more efficient way
to obtain samples from epidemiologically linked cases. The
Maricopa study and our Carolinas study, which were con-
ducted in different parts of the country, suggest that subtype
14f may be the predominant strain circulating in the United
States. However, additional investigations involving molecular
differentiation of T. pallidum strains from other parts of the
country are needed for further elucidation.
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